Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

doi:10.4254/wjh.v16.i1.75

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2223)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

1121

Figures (1-4)

110

Tables (1-5)

118

Sum=1400

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

106

Download

270

Sum=376

Publishing Process of This Article

Item

Count

Browse

139

Download

240

Sum=379

Jan 27, 2024 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Jan 27, 2024; 16(1): 75-90
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.75

Table 2 Correlations between hepatocarcinogenesis, autophagy and epigenetic markers

Variables¹		microRNAs			Hepatocarcinogenesis					Autophagy and Epigenetic
Variables¹		miR-26b	miR-224	miR-34a	*Mmp2*	*Mmp9*	*Afp*	*Tuba1c*	*Aldob*	*Becn1*	*p62/Sqstm1*	*Map1lc3b*	*Ezh2*	*Carm1*	p62 protein	MAP1LC3B protein
microRNAs	miR-122	-0.235	0.075	0.400^a	0.195	0.422	-0.189	0.085	0.030	-0.502^a	-0.673^b	-0.554^a	-0.760^b	-0.375	-0.245	0.017
	miR-26b		-0.360	0.538^a	-0.071	0.203	0.199	-0.090	-0.113	-0.089	0.164	-0.047	-0.005	0.525^a	-0.124	0.186
	miR-224			-0.195	0.041	-0.241	-0.201	0.025	0.153	-0.298	-0.022	0.032	-0.061	-0.335	-0.007	-0.393
	miR-34a				0.110	0.426	0.123	0.110	-0.127	-0.461^a	-0.340	-0.612^b	-0.584^b	0.181	-0.400	-0.191
Hepatocarcinogenesis	Mmp2					0.742^b	0.704^b	0.957^b	0.548^b	-0.321	-0.133	-0.321	-0.361	-0.286	-0.318	-0.368
	Mmp9						0.521^a	0.703^b	0.292	-0.398	-0.276	-0.351	-0.586^b	-0.278	-0.547^a	-0.229
	Afp							0.702^b	0.468^a	-0.086	0.049	-0.173	0.038	-0.073	-0.328	-0.078
	Tuba1c								0.644^b	-0.324	-0.058	-0.281	-0.350	-0.282	-0.258	-0.246
	Aldob									-0.137	-0.042	0.186	0.111	-0.314	-0.032	0.174
Autophagy and Epigenetic	Becn1										0.541^b	0.771^b	0.597^b	0.433	0.631^b	0.302
	p62/Sqstm1											0.657^b	0.609^b	0.459	0.554^a	0.265
	Map1lc3b												0.718^b	0.230	0.512^a	0.343
	Ezh2													0.288	0.342	0.253
	Carm1														0.185	-0.044
	p62 protein															0.406

¹Variables were evaluated by Spearman's r correlation coefficient: Moderate (0.3 < r < 0.6), strong (0.6 < r < 0.9) or very strong (0.9 < r < 1.0).

^aP < 0.05, correlation significant at the 0.05 level.

^bP < 0.01, correlation significant at the 0.01 level.

Afp: Alpha-fetoprotein; Aldo-B: Aldolase-B; Becn-1: Beclin-1; Carm1: Coactivator associated arginine methyltransferase-1; Ezh-2: Enhancer of zeste homolog-2; Map1lc3b: Autophagy-related factor LC3A/B; Mmp: Metalloproteinases; p62/Sqstm1: P62/sequestosome-1; Tuba1c: Tubulin alpha-1c.

Citation: Michalczuk MT, Longo L, Keingeski MB, Basso BS, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CP, Uribe-Cruz C, Cerski CTS, Filippi-Chiela E, Álvares-da-Silva MR. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. World J Hepatol 2024; 16(1): 75-90
URL: https://www.wjgnet.com/1948-5182/full/v16/i1/75.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i1.75